Equities

Xiangyu Medical Co Ltd

688626:SHH

Xiangyu Medical Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)21.72
  • Today's Change-10.41 / -32.40%
  • Shares traded642.49k
  • 1 Year change-58.24%
  • Beta1.6198
Data delayed at least 15 minutes, as of Sep 13 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments8201,3581,478
Total Receivables, Net895149
Total Inventory241223159
Prepaid expenses383227
Other current assets, total6.134.874.06
Total current assets1,1941,6681,717
Property, plant & equipment, net867419177
Goodwill, net------
Intangibles, net208204209
Long term investments2591717
Note receivable - long term484350
Other long term assets------
Total assets2,5922,3682,183
LIABILITIES
Accounts payable1039733
Accrued expenses403525
Notes payable/short-term debt51263.03
Current portion long-term debt/capital leases------
Other current liabilities, total178194120
Total current liabilities372352181
Total long term debt8.4400
Total debt59263.03
Deferred income tax--111.83
Minority interest171211
Other liabilities, total1046554
Total liabilities501440248
SHAREHOLDERS EQUITY
Common stock160160160
Additional paid-in capital1,2941,2941,294
Retained earnings (accumulated deficit)736546481
Treasury stock - common(99)(73)--
Unrealized gain (loss)------
Other equity, total------
Total equity2,0911,9281,935
Total liabilities & shareholders' equity2,5922,3682,183
Total common shares outstanding157158160
Treasury shares - common primary issue2.892.270
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.